EP3355889
DÍAMÍNÓPÝRIMIDÍN P2X3 OG P2X2/3 VIÐTAKAMIÐLAR TIL NOTA VIÐ HÓSTAMEÐFERÐ
:
EP einkaleyfi í gildi á Íslandi:
23.9.2016:
15.2.2023:
16852340.5
:
24.4.2023:
15.5.2023
:
22.9.2036:
22.9.2025:
30.9.2025
:
DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULATORS FOR USE IN THE TREATMENT OF COUGH
23.9.2016
15.2.2023
24.4.2023
15.5.2023
22.9.2025
:
Afferent Pharmaceuticals Inc.:
126 East Lincoln Avenue Rahway, New Jersey 07065, US
:
FORD, Anthony, P.:
San Mateo, California 94403, US
:
GLAUB, Kathleen Sereda:
San Mateo, California 94403, US
:
KITT, Michael, M.:
San Mateo, California 94403, US
:
SMITH, Steven:
San Mateo, California 94403, US
:
G.H. Sigurgeirsson ehf.:
Borgartúni 26, 105, Reykjavík,
:
201562234584 P:
29.9.2015:
US
:
201662336381 P:
13.5.2016:
US
:
US2016053223:
23.9.2016
:
A61K 9/00, A61K 9/06, A61K 9/10, A61K 9/20, A61K 9/48, A61K 31/505, A61K 45/06, A61K 47/38, A61K 47/44, A61P 11/14, A61P 43/00
: 8
: 30.6.2023
: 22.9.2024
: Árnason Faktor ehf.
: 9
: 15.8.2024
: 22.9.2025
: Árnason Faktor ehf.